Baldeiras I, Santana I, Leitão MJ, Gens H, Pascoal R, Tábuas-Pereira M, Beato-Coelho J, Duro D, Almeida MR, Oliveira CR (2018) Addition of the Aβ42/40 ratio to the cerebrospinal fluid biomarker profile increases the predictive value for underlying Alzheimer’s disease dementia in mild cognitive impairment. Alzheimer’s Res Ther 10(1):33. https://doi.org/10.1186/s13195-018-0362-2
Barker MJ, Greenwood KM, Jackson M, Crowe SF (2004) Cognitive effects of long-term benzodiazepine use: a meta-analysis. CNS Drugs 18(1):37–48. https://doi.org/10.2165/00023210-200418010-00004
Article PubMed CAS Google Scholar
Basavarajappa BS, Subbanna S (2024) Unlocking the epigenetic symphony: histone acetylation’s impact on neurobehavioral change in neurodegenerative disorders. Epigenomics 16(5):331–358. https://doi.org/10.2217/epi-2023-0428
Article PubMed CAS Google Scholar
Batalla A, Bhattacharyya S, Yücel M, Fusar-Poli P, Crippa JA, Nogué S, Torrens M, Pujol J, Farré M, Martin-Santos R (2013) Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings. PLoS ONE 8(2):e55821. https://doi.org/10.1371/journal.pone.0055821
Article PubMed PubMed Central CAS Google Scholar
Behzad M, Zirak N, Madani GH, Baidoo L, Rezaei A, Karbasi S, Sadeghi M, Shafie M, Mayeli M, Initiative ADN (2023) CSF-targeted proteomics indicate amyloid-beta ratios in patients with Alzheimer’s dementia spectrum. Int J Alzheimer’s Dis 2023:5336273
Bernstein C (2022) DNA methylation and establishing memory. Epigenet Insights 15:25168657211072500. https://doi.org/10.1177/25168657211072499
Article PubMed PubMed Central Google Scholar
Beuzen JN, Taylor N, Wesnes K, Wood A (1999) A comparison of the effects of olanzapine, haloperidol and placebo on cognitive and psychomotor functions in healthy elderly volunteers. J Psychopharmacol 13(2):152–158. https://doi.org/10.1177/026988119901300207
Article PubMed CAS Google Scholar
Blume J, Dhanasekara CS, Kahathuduwa CN, Mastergeorge AM (2024) Central executive and default mode networks: an appraisal of executive function and social skill brain-behavior correlates in youth with autism spectrum disorder. J Autism Dev Disord 54(5):1882–1896. https://doi.org/10.1007/s10803-023-05961-4
Booij L, Szyf M, Carballedo A et al (2015) DNA methylation of the serotonin transporter gene in peripheral cells and stress-related changes in hippocampal volume: a study in depressed patients and healthy controls. PLoS ONE 10:e0119061. https://doi.org/10.1371/journal.pone.0119061
Article PubMed PubMed Central CAS Google Scholar
Bora E, Murray RM (2019) Cognitive impairment in schizophrenia and the role of antipsychotic medication. World Psychiatr 18(2):194–202. https://doi.org/10.1002/wps.20604
Braga DL, Mousovich-Neto F, Tonon-da-Silva G, Salgueiro WG, Mori MA (2020) Epigenetic changes during ageing and their underlying mechanisms. Biogerontology 21(4):423–443. https://doi.org/10.1007/s10522-020-09874-y
Brown HT, Green MK (2023) Therapeutic uses and side effects of psychotropic drugs: a review. Ment Health Pharmacol 12:45–59. https://doi.org/10.1016/j.mpharm.2023.02.001
Buchanan M, Boulanger L (2021) Cognitive effects of long-term benzodiazepine use: a narrative review. J Clin Psychiatry 82(3):20r13562. https://doi.org/10.4088/JCP.20r13562
Canivet A, Albinet CT, André N, Pylouster J, Rodríguez-Ballesteros M, Kitzis A, Audiffren M (2015) Effects of BDNF polymorphism and physical activity on episodic memory in the elderly: a cross-sectional study. Eur Rev Aging Phys Act 12:15. https://doi.org/10.1186/s11556-015-0159-2
Article PubMed PubMed Central Google Scholar
Capogna E, Watne LO, Sørensen Ø, Guichelaar CJ, Idland AV, Halaas NB, Blennow K, Zetterberg H, Walhovd KB, Fjell AM, Vidal-Piñeiro D (2023) Associations of neuroinflammatory IL-6 and IL-8 with brain atrophy, memory decline, and core AD biomarkers - in cognitively unimpaired older adults. Brain Behav Immun 113:56–65. https://doi.org/10.1016/j.bbi.2023.06.027
Article PubMed CAS Google Scholar
Chan JKN, Wong CSM, Fang CZ et al (2024) Mortality risk and mood stabilizers in bipolar disorder: a propensity-score-weighted population-based cohort study in 2002–2018. Epidemiol Psychiatr Sci 33:e31. https://doi.org/10.1017/S2045796024000337
Article PubMed PubMed Central Google Scholar
Chandramouleeshwaran S, Khan WU, Inglis F, Rajji TK (2023) Impact of psychotropic medications on cognition among older adults: a systematic review. Int Psychogeriatr. https://doi.org/10.1017/S1041610223000844
Chen L, Huang T, Ma D, Chen YC (2022) Altered default mode network functional connectivity in Parkinson’s disease: a resting-state functional magnetic resonance imaging study. Front Neurosci 16:905121. https://doi.org/10.3389/fnins.2022.905121
Article PubMed PubMed Central Google Scholar
Chiu C-C, Hsu K-C (2023) Mechanisms of action of mood stabilizers: a comprehensive review. J Affect Disord 311:166–180. https://doi.org/10.1016/j.jad.2023.01.015
Cohen K, Mama Y, Rosca P, Pinhasov A, Weinstein A (2020) Chronic use of synthetic cannabinoids is associated with impairment in working memory and mental flexibility. Front Psych 11:602. https://doi.org/10.3389/fpsyt.2020.00602
Coliță D, Coliță CI, Hermann DM, Coliță E, Doeppner TR, Udristoiu I, Popa-Wagner A (2022) Therapeutic use and chronic abuse of CNS stimulants and anabolic drugs. Curr Issues Mol Biol 44(10):4902–4920. https://doi.org/10.3390/cimb44100333
Article PubMed PubMed Central CAS Google Scholar
Colyer-Patel K, Romein C, Kuhns L et al (2024) Recent evidence on the relation between cannabis use, brain structure, and function: highlights and challenges. Curr Addict Rep 11:371–383. https://doi.org/10.1007/s40429-024-00557-z
Coppede F (2022) Targeting the epigenome to treat neurodegenerative diseases or delay their onset: a perspective. Neural Regen Res 17(8):1745–1747. https://doi.org/10.4103/1673-5374.332145
Article PubMed PubMed Central CAS Google Scholar
Cowan RL, Lyoo IK, Sung SM, Ahn KH, Kim MJ, Hwang J, Haga E, Vimal RL, Lukas SE, Renshaw PF (2003) Reduced cortical gray matter density in human MDMA (Ecstasy) users: a voxel-based morphometry study. Drug Alcohol Depend 72(3):225–235. https://doi.org/10.1016/j.drugalcdep.2003.07.001
Article PubMed CAS Google Scholar
Coyle JT et al (2023) NMDA receptor and schizophrenia: from pathophysiology to treatment. Nat Rev Drug Discov 22:56–73
Crichton M, Dissanayaka T, Marx W et al (2024) Does medicinal cannabis affect depression, anxiety, and stress in people with cancer? A systematic review and meta-analysis of intervention studies. Maturitas 184:107941. https://doi.org/10.1016/j.maturitas.2024.107941
Article PubMed CAS Google Scholar
Crowe SF, Stranks EK (2018) The residual medium and long-term cognitive effects of benzodiazepine use: an updated meta-analysis. Arch Clin Neuropsychol 33(7):901–911. https://doi.org/10.1093/arclin/acx120
Cutler AJ, Mattingly GW, Maletic V (2023) Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder. Transl Psychiatry 13:228. https://doi.org/10.1038/s41398-023-02514-2
Article PubMed PubMed Central Google Scholar
Dafsari FS, Jessen F (2020) Depression—an underrecognized target for prevention of dementia in Alzheimer’s disease. Transl Psychiatry 10:160. https://doi.org/10.1038/s41398-020-0839-1
Article PubMed PubMed Central Google Scholar
Dantzer R, Kelley KW (2007) Stress and inflammation: a neuroendocrine perspective. Neurosci Biobehav Rev 31(1):1–9. https://doi.org/10.1016/j.neubiorev.2006.05.001
Delacrétaz A, Glatard A, Dubath C et al (2019) Psychotropic drug-induced genetic-epigenetic modulation of CRTC1 gene is associated with early weight gain in a prospective study of psychiatric patients. Clin Epigenet 11:198. https://doi.org/10.1186/s13148-019-0792-0
Comments (0)